
Life sciences job openings · Updated 2026-08-13
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
The post Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) appeared first on Travere .
Travere Therapeutics to Participate at Upcoming Investor Conferences
The post Travere Therapeutics to Participate at Upcoming Investor Conferences appeared first on Travere .
Travere Therapeutics Reports Second Quarter 2026 Financial Results
The post Travere Therapeutics Reports Second Quarter 2026 Financial Results appeared first on Travere .
Travere Therapeutics to Report Second Quarter 2026 Financial Results
The post Travere Therapeutics to Report Second Quarter 2026 Financial Results appeared first on Travere .
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
The post Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) appeared first on Travere .
Travere Therapeutics Announces Planned Retirement of Chief Research Officer in 2027
The post Travere Therapeutics Announces Planned Retirement of Chief Research Officer in 2027 appeared first on Travere .
From official company newsrooms and press releases.
Company description, mission, culture, and benefits — visible after this page is claimed and verified.
Sign up free to search all 20+ openings with AI-powered matching.
Search Travere Therapeutics JobsProfile generated from publicly available hiring data.
·Are you Travere Therapeutics? Claim this page or contact us